Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Additional glitazone fracture data

The Archives of Internal Medicine has published the results of an analysis that examined the association between the use of glitazones or other oral anti-diabetic drugs and the risk of fracture.

The analysis queried the UK General Practice Research Database for patients aged 30 to 89 years who had a fracture between January 1994 and December 2005. Control patients were matched for age, gender and general practice attended.

The study identified 1,020 case patients with a low trauma fracture and 3,728 controls. After correction for several factors including age, body mass index and co-morbidities users of glitazones were at statistically higher risk of fractures; odds ratio 2.43 (95% confidence interval [CI], 1.49-3.95). The risk also appeared to be dose related. There were no detectable differences associated with the other oral anti-diabetic drugs.

The authors conclude that, "this analysis provides further evidence of a possible association between long-term use of thiazolidinediones [glitazones] and fractures".

Action: Clinicians should reserve glitazone use for patients who are contraindicated to or cannot tolerate metformin and/or a sulphonylurea.

Share 'Additional glitazone fracture data' on Email Share 'Additional glitazone fracture data' on Delicious Share 'Additional glitazone fracture data' on Digg Share 'Additional glitazone fracture data' on Facebook Share 'Additional glitazone fracture data' on Google+ Share 'Additional glitazone fracture data' on reddit Share 'Additional glitazone fracture data' on StumbleUpon Share 'Additional glitazone fracture data' on Twitter

atomic-wealth

No Comments to “Additional glitazone fracture data”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,668 spam comments.

atomic-wealth
fond-illness
summer